Catalyst Wire Dossier Catalyst Wire Dossier

monovalent pandemic H5N1 vaccine

null · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for monovalent pandemic H5N1 vaccine, covering 2014-04-16 to 2014-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults [Phase 2]

See pricing